Loading page
Loading page
Loading substance route
These doses are tentative and further research is recommended.
Classified as habit-forming. As a cathinone stimulant, it likely carries psychological addiction potential comparable to related compounds, though specific data on 3-CMC abuse patterns is lacking.
Between November 2019 and June 2021, ten deaths linked to 3-CMC exposure were reported in Poland (7 cases) and Sweden (3 cases). Other substances were present in six of these cases, with alcohol being the only additional substance in two cases. Causes of death included multi-organ trauma from a traffic accident, toxic effects of 3-CMC, and polysubstance intoxication. Details regarding dosage and administration routes are lacking.
Episodes of psychosis have been reported as a potential effect, consistent with other cathinone compounds. Visual and auditory hallucinations are also listed among possible effects.
3-CMC first appeared in 2014, emerging as part of the broader wave of synthetic cathinones entering the European designer drug market during this period. The substance was primarily sold through online vendors, with initial distribution concentrated in Germany, Poland, the Netherlands, and Sweden.…
European Commission control measures (March 2022)
Banned since October 2015. Following this prohibition, production reportedly shifted primarily to India, with little supply originating from within Europe.
As of March 2022, the European Commission implemented control measures for 3-CMC based on a risk assessment conducted by the EU Drugs Agency (EMCDDA) in November 2021. Several member states had already implemented generic controls prior to this EU-wide decision.
11 sources cited